المؤلفون: Philip J. Mease, Howard Thom, Steffen M Jugl, Ernest Choy, K Gandhi, Chrysostomos Kalyvas, Luminita Pricop, Peter Nash, Matthias Hunger

المصدر: European Journal of Rheumatology, Vol 6, Iss 3, Pp 113-121 (2019)
Mease, P J, Choy, E, Nash, P, Kalyvas, C, Hunger, M, Pricop, L, Gandhi, K, Jugl, S & Thom, H 2019, ' Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison ', European Journal of Rheumatology, vol. 6, no. 3, pp. 113-121 . https://doi.org/10.5152/eurjrheum.2019.19057Test

مصطلحات موضوعية: musculoskeletal diseases, lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, matching-adjusted indirect comparison, Population, Placebo, Etanercept, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Internal medicine, Medicine, 030212 general & internal medicine, education, skin and connective tissue diseases, 030203 arthritis & rheumatology, psoriatic arthritis, education.field_of_study, business.industry, secukinumab, Odds ratio, medicine.disease, Rheumatology, Confidence interval, Comparative effectiveness, Original Article, Secukinumab, business, lcsh:RC581-607, etanercept, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a7f1619a8309145092fb366ca7284eTest
https://www.eurjrheumatol.org/eng/makale/3224/219/Full-TextTest

المؤلفون: K Gandhi, Vibeke Strand, Peter Nash, Brian Porter, Matthias Hunger, Howard Thom, Steffen M Jugl, Chrysostomos Kalyvas, Walter P. Maksymowych, Yusuf Yazici

المصدر: European Journal of Rheumatology

مصطلحات موضوعية: medicine.medical_specialty, matching-adjusted indirect comparison, Population, comparative effectiveness, Logistic regression, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, ankylosing spondylitis, Adalimumab, medicine, education, 030203 arthritis & rheumatology, Ankylosing spondylitis, education.field_of_study, business.industry, secukinumab, 030503 health policy & services, Odds ratio, medicine.disease, Confidence interval, Indirect comparison, Original Article, Secukinumab, 0305 other medical science, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4eb329f6ff5b80aa2f8ec9194af8ad4Test
https://doi.org/10.5152/eurjrheum.2018.18162Test